This section contains the medicaid agency's rules for the endorsing practitioner therapeutic interchange program (TIP). TIP is established under RCW 69.41.190 and 70.14.050.
(1) TIP applies only to drugs:
- (a) Within therapeutic classes on the Washington preferred drug list (Washington PDL);
- (b) Included in a motion passed by the pharmacy and therapeutics (P&T) committee; and
- (c) Prescribed by an endorsing practitioner.
(2) TIP does not apply to a drug when:
- (a) The P&T committee determines that TIP does not apply to the drug or its therapeutic class on the Washington PDL;
- (b) Prescribed by a nonendorsing practitioner;
- (c) The endorsing practitioner signs the prescription "dispense as written (DAW)"; or
- (d) Otherwise prohibited under RCW 69.41.190.
- (3) The agency may impose nonendorsing status on an endorsing practitioner only under the circumstances outlined in RCW 69.41.190.
- (4) Except as otherwise provided in subsection (5) of this section, the agency may restrict a client's first course of treatment within a therapeutic class, according to the provisions in RCW 69.41.190.
- (5) In accordance with WAC 182-530-4125(3) and 182-501-0165, the agency will request and review the endorsing practitioner's medical justification for preferred and nonpreferred brand name drugs and nonpreferred generic drugs for the client's first course of treatment.
[Statutory Authority: RCW 41.05.021 and 41.05.160. WSR 17-07-001, § 182-530-4150, filed 3/1/17, effective 4/1/17; WSR 16-01-046, § 182-530-4150, filed 12/9/15, effective 1/9/16. WSR 11-14-075, recodified as § 182-530-4150, filed 6/30/11, effective 7/1/11. Statutory Authority: RCW 74.04.050, 74.09.700, 74.08.090, 2009 c 575. WSR 10-06-011, § 388-530-4150, filed 2/19/10, effective 3/22/10. Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.700, 2008 c 245. WSR 08-21-107, § 388-530-4150, filed 10/16/08, effective 11/16/08. Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.530, and 74.09.700. WSR 07-20-049, § 388-530-4150, filed 9/26/07, effective 11/1/07.]